Top

Valsartan and Cancer

The FDA recalled Valsartan in July 2018 after finding the probable human carcinogen N-nitrosodimethylamine (NDMA) had contaminated the drug in a supplier’s facility. This carcinogenic substance has been linked to serious injuries such as an increased risk of liver, kidney, colorectal, stomach, and pancreatic cancer. If you or a loved one took Valsartan and contracted cancer, contact our dangerous drug attorneys at GoldenbergLaw.

Did you receive a recall letter?

Many pharmacies and clinics have sent out letters notifying their patients of this recall. If you received a letter or are taking this drug, you should contact your doctor immediately to understand your treatment options.

Case Quick Facts

The Problem

Valsartan is an angiotensin receptor blocker (ARB) that is used to treat high blood pressure and congestive heart failure. It was approved by the FDA in 1996. In 2018, investigators found that certain lots of Valsartan were contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen. NDMA was found in Valsartan tablets produced by three different facilities:  Zhejiang Huahai Pharmaceuticals in China, Hetero Labs Limited, in India, and Zhejiang Tianyu, in China.

According to the Environmental Protection Agency, N-nitrosodimethylamine was formerly used in the production of rocket fuel, antioxidants, additives for lubricants, and softeners for copolymers.

The Injuries

Short-term exposure to NDMA can lead to liver damage. Long-term exposure can lead to:

  • Liver cancer
  • Kidney cancer
  • Stomach cancer
  • Intestinal/colon/colorectal cancer
  • Pancreatic cancer
The Defendant(s)

Novartis is the manufacturer of Valsartan.

Certain lots of Valsartan have been recalled, and the list continues to grow. If you are concerned that your medication was contaminated, you can compare your prescription with this list to determine if it was recalled.

GoldenbergLaw Can Help

If you or a loved one received a Valsartan recall letter and were diagnosed with cancer, contact us.

Do I Qualify?

Free Consultations

Contact GoldenbergLaw today for a free consultation. Our consultations cost you nothing, including an obligation. The only time you’ll get a fee from us is if we win your case. Get your free consultation today and get started on your path towards justice and compensation.

Contact Us Call 800-903-1643

Recall – July 13, 2018

The FDA issued a recall for certain lots of Valsartan. These lots were allegedly contaminated with NDMA.

Why Choose GoldenbergLaw?

If you find yourself wanting to pursue a Valsartan lawsuit, GoldenbergLaw has the people and resources to help you out. Our team of Valsartan lawyers has experience in related cases and will fight to bring you justice.

Thousands of Successful Settlements

Over 30 Years of Experience

Admissions in Courts Nationwide

Meet Your Valsartan Team

Attorney Referral

Have a potential client we could help?

Referral Form

Free Consultation

Call us. You’ll sleep better.

Schedule Now